Hillstream BioPharma Patents – Key Insights and Stats

Hillstream BioPharma has a total of 28 patents globally, out of which 4 have been granted. Of these 28 patents, more than 85% patents are active. The United States of America is where Hillstream BioPharma has filed the maximum number of patents. Parallelly, United States of America seems to be the main focused R&D centre and also United Kingdom is the origin country of Hillstream BioPharma.

Hillstream BioPharma was founded in 2017. The company Hillstream BioPharma is in the biotechnology industry. The company creates brand-new therapeutic candidates that target ferroptosis, a recently discovered anti-cancer mechanism that causes iron-mediated cell death (IMCD) in the case of tumours that are resistant to treatment. International clients are served by Hillstream BioPharma.

Do read about some of the most popular patents of Hillstream BioPharma which have been covered by us in this article and also you can find Hillstream BioPharma patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Hillstream BioPharma patent portfolio.

How many patents do the Founder and CEO of Hillstream BioPharma have?

The Founder and CEO Randy Milby have 13 patents.

How many patents does Hillstream BioPharma have?

Hillstream BioPharma has a total of 28 patents globally. These patents belong to 11 unique patent families. Out of 28 patents, 24 patents are active.

How Many Patents did Hillstream BioPharma File Every Year?

Hillstream BioPharma Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantHillstream BioPharma Applications FiledHillstream BioPharma Patents Granted
202252
20218
201951
201871
20171
20161
20131

How many Hillstream BioPharma patents are Alive/Dead?

Worldwide Patents

Hillstream BioPharma Patent Portfolio

How Many Patents did Hillstream BioPharma File in Different Countries?

Hillstream BioPharma Worldwide Patent Filing

Countries in which Hillstream BioPharma Filed Patents

CountryPatent
United States Of America9
Australia3
Canada3
Europe3
Hong Kong (S.A.R.)2
China2

Where are Research Centers of Hillstream BioPharma Patents Located?

R&D Centres of Hillstream BioPharma

List of Hillstream BioPharma patents

Hillstream BioPharma PatentTitle
US11484507B2Polymeric Nanoparticles Providing Nucleic Acids Encoding Tnf-Α
US11246904B2Polymeric Nanoparticles And A Process Of Preparation Thereof
US10364253B2Salinomycin Derivatives And Therapeutic Uses Thereof
US10092617B2Polymeric Nanoparticles And A Process Of Preparation Thereof
US20230157969A1Polymeric Nanoparticles Providing Nucleic Acids Encoding Tnf-A
US20220175874A1Polymeric Nanoparticles And A Process Of Preparation Thereof
US20220175688A1Polymeric Nanoparticles
US20200046648A1Polymeric Nanoparticles Comprising Salinomycin
EP4171543A2Nanoparticles And Methods Of Manufacture Thereof
EP3714257A4Polymeric Nanoparticles Comprising Bortezomib
EP3823589A1Polymeric Nanoparticles Comprising Salinomycin
CN113164375APolymeric Nanoparticles Comprising Salinomycin
CN111373246APolymeric Nanoparticles Comprising Bortezomib
WO2023034605A1Polymeric Nanoparticles Comprising A Histone Deacetylase 6 / Phosphoinositide 3-Kinase-8 Dual Inhibitor And Related Methods
WO2022251844A1Polymeric Nanoparticles Comprising Chemotherapeutic Compounds And Related Methods
WO2022187849A1Salinomycin Derivatives And Uses Thereof
WO2022178510A1Nanoparticles For Use In Treating Viral Infections
AU2021300174A1Nanoparticles And Methods Of Manufacture Thereof
CA3186633A1Nanoparticles And Methods Of Manufacture Thereof
AU2019307629A1Polymeric Nanoparticles Comprising Salinomycin
CA3105731A1Polymeric Nanoparticles Comprising Salinomycin
CA3079751A1Polymeric Nanoparticles Comprising Bortezomib
HK40045678APolymeric Nanoparticles Comprising Salinomycin
HK40038621APolymeric Nanoparticles Comprising Bortezomib
US20190151340A1Polymeric Nanoparticles Comprising Bortezomib
WO2022006271A3Nanoparticles And Methods Of Manufacture Thereof
WO2019104001A1Polymeric Nanoparticles Comprising Bortezomib
AU2018372924A1Polymeric Nanoparticles Comprising Bortezomib

What are Hillstream BioPharma key innovation segments?

What Technologies are Covered by Hillstream BioPharma?

The chart below distributes patents filed by Hillstream BioPharma in different countries on the basis of the technology protected in patents. It also represents the markets where Hillstream BioPharma thinks it’s important to protect particular technology inventions.

R&D Focus: How has Hillstream BioPharma search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Hillstream BioPharma?

Table of Content

Insights you may find interesting

Related Articles

Pavegen Patents – Insights & Stats (Updated 2024)

Pavegen has a total of 36 patents globally, out of which 26 have been granted. Of these 36 patents, more than 47% patents are active. United Kingdom is where Pavegen has filed the maximum number of patents, followed by Europe (EPO) and Austria. Parallelly, United Kingdom seems to be the

Read More »

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.